Prime Medicine, Inc. Common Stock Earnings

The next earnings date for Prime Medicine, Inc. Common Stock has not yet been scheduled.

Analyst Estimates of Prime Medicine, Inc. Common Stock Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Prime Medicine, Inc. Common Stock Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/07/2025---$-0.3225.58%
10/31/2025---$0100.00%
08/07/2025---$-0.414.65%
08/06/2025---$0100.00%
05/09/2025---$-0.40-27.96%
02/28/2025---$-0.310.39%
11/13/2024---$-0.44-4.71%
08/08/2024---$-0.46-18.86%
05/10/2024Before Market$-0.446.38%
03/01/2024Before Market$-0.72-41.18%
11/03/2023After Market$-0.55-19.57%
08/07/2023After Market$-0.47-11.90%
05/11/2023Before Market$-0.44-7.32%
03/09/2023Before Market$-0.5613.85%
11/14/2022After Market$-0.73---
05/06/2022---$-0.32---
12/20/2021---$-0.24---

More About Prime Medicine, Inc. Common Stock

Country
USA
Full Time Employees
214

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Prime Medicine, Inc. Common Stock Earnings” Can Refer to the Prime Medicine, Inc. Common Stock Earnings Date

Some people say “Prime Medicine, Inc. Common Stock earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Prime Medicine, Inc. Common Stock position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Prime Medicine, Inc. Common Stock Stock on the Earnings Date

If you own Prime Medicine, Inc. Common Stock stock (PRME) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Prime Medicine, Inc. Common Stock might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Prime Medicine, Inc. Common Stock shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Prime Medicine, Inc. Common Stock Earnings

You can contact us any time if you would like to ask questions about Prime Medicine, Inc. Common Stock earnings or anything else related to the stock market.